Skip to main content

Impact BioMedical, Inc. (IBO) Stock

Impact BioMedical, Inc. Stock Details, Movements and Public Alerts

Stock Details

Impact BioMedical, Inc. (IBO), a prominent company in the healthcare sector within the biotechnology industry, is based in United States and primarily trades on the ASE.Currently, the stock is trading at $3.68. Over the past 52 weeks, it has ranged between $2.43 and $10.51. This places the current price at 35.0% of its 52-week high and 51.4% above its 52-week low. Recent trading volume was recorded at 11,719. The 14-day Relative Strength Index (RSI) stands at 39.01, suggesting neutral conditions. The stock is currently trading below its 50-day moving average of $5.37 by 31.47%. Similarly, it is below its 200-day moving average of $6.34 by 41.96%. The MACD histogram is 0.01, indicating bullish momentum (MACD Line: -0.62, Signal Line: -0.63).

52-Week Range

$10.51 - $2.43

-64.97% from high · +51.44% from low

Avg Daily Volume

14,747

20-day average

100-day avg: 96,636

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

0.32

Below market average

Price to Book

2.86

EV/EBITDA

-8.60

EPS (TTM)

$11.11

Price to Sales

878.78

Beta

2.73

More volatile than market

Q:How is IBO valued relative to its earnings and growth?
Impact BioMedical, Inc. trades at a P/E ratio of 0.32, which is below the market average of approximately 20. This lower valuation could indicate the market has modest growth expectations, or it might represent an undervalued opportunity if the fundamentals are strong.
Q:What is IBO's risk profile compared to the market?
With a beta of 2.73, Impact BioMedical, Inc. is significantly more volatile than the market. For every 10% market move, this stock tends to move 27% in the same direction. Higher beta stocks offer greater potential returns but with increased risk. The price-to-book ratio of 2.86 shows investors value the company above its book value, which often reflects intangible assets or growth prospects.

Performance & Growth

Profit Margin

2260.00%

Operating Margin

-23400.00%

EBITDA

$-3,952,000

Return on Equity

23.46%

Return on Assets

-17.79%

Revenue Growth (YoY)

-57.10%

Q:How profitable and efficient is IBO's business model?
Impact BioMedical, Inc. achieves a profit margin of 2260.00%, meaning it retains $2260.00 from every $100 in revenue after all expenses. This is an impressive margin, indicating strong pricing power and efficient cost management that allows the company to generate substantial profits. The operating margin of -23400.00% reveals how efficiently the company runs its core business operations before interest and taxes. With ROE at 23.46% and ROA at -17.79%, the company generates strong returns on invested capital.
Q:What are IBO's recent growth trends?
Impact BioMedical, Inc.'s revenue declined by 57.10% year-over-year, indicating challenges in maintaining sales momentum. This contraction may reflect market headwinds, competitive pressures, or strategic transitions. These growth metrics should be evaluated against Biotechnology industry averages for proper context.

Company Size & Market

Market Cap

$30.8M

Revenue (TTM)

$35,000

Revenue/Share (TTM)

$0.01

Shares Outstanding

8.54M

Book Value/Share

$1.26

Asset Type

EQUITY

Q:What is IBO's market capitalization and position?
Impact BioMedical, Inc. has a market capitalization of $30.8M, classifying it as a small-cap stock (under $2B). Small-caps offer significant growth potential but come with higher volatility and risk. They can be more sensitive to economic conditions but may provide outsized returns if successful. With 8.54M shares outstanding, the company's ownership is relatively concentrated. As a participant in the Biotechnology industry, it competes with other firms in this sector.
Q:How does IBO's price compare to its book value?
Impact BioMedical, Inc.'s book value per share is $1.26, while the current stock price is $3.68, resulting in a price-to-book (P/B) ratio of 2.92. This reasonable premium to book value suggests the market values the company's earnings power and intangible assets appropriately. Most profitable companies trade between 1-3x book value. As EQUITY, this represents a specific type of security.

Fundamentals last updated: Oct 24, 2026, 02:12 AM

Technical Indicators

RSI (14-day)

39.01

Neutral

50-Day Moving Average

$5.37

-31.47% below MA-50

200-Day Moving Average

$6.34

-41.96% below MA-200

MACD Line

-0.62

MACD Signal

-0.63

MACD Histogram

0.01

Bullish

Q:What does IBO's RSI value tell investors?
The RSI (Relative Strength Index) for IBO is currently 39.01, indicating the stock is showing bearish momentum (30-40 range). Selling pressure is evident but not extreme. This often occurs during pullbacks in uptrends or early stages of downtrends. Combined with the price being below the 50-day moving average, this confirms bearish conditions.
Q:How should traders interpret IBO's MACD and moving average crossovers?
MACD analysis shows the MACD line at -0.62 above the signal line at -0.63, with histogram at 0.01. This bullish crossover suggests upward momentum is building. The narrow histogram suggests a potential trend change ahead. The 50-day MA ($5.37) is below the 200-day MA ($6.34), forming a death cross pattern that often warns of extended weakness. Price is currently below both MAs, confirming weakness.

Indicators last updated: Oct 24, 2026, 01:04 AM

Active Alerts

No active alerts for this stock.

Be the first to set up an alert for IBO and get notified when the price changes.

Stay Ahead of the Market with Impact BioMedical, Inc. Alerts

Set up price alerts for Impact BioMedical, Inc. and get notified instantly when the price hits your target. Never miss an important price movement again.